Catalyst Wire Dossier Catalyst Wire Dossier

beta-hydroxybutyrate infusion

beta-hydroxybutyrate
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for beta-hydroxybutyrate infusion, covering 2017-11-01 to 2017-11-01. Get the full timeline:

Most recent: Clinical Trial Update: Substrate Metabolism, Growth Hormone Signaling (GH), and Insulin Sensitivity During GH and Ketone Bodies Infusion [NA]

See pricing